QUantitative Flow Ratio Or Angiography for the assessMent of nOn-culprit Lesions
NCT ID: NCT04808310
Last Updated: 2024-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
200 participants
INTERVENTIONAL
2020-10-01
2024-04-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Goals of the study are:
* To investigate whether decision-making based on quantitative flow reserve (QFR) is associated with a decrease in angina 3 months after an ACS
* To investigate whether use of QFR is associated with an improved prognosis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Angio-based Fractional Flow Reserve to Predict Adverse Events After Stent Implantation
NCT02811796
PrOgnostic Implications of PRe-stent Pullback Pressure GradIent and Post-stent Quantitative Flow Ratio in Patients UnderGoing Percutaneous Coronary INtervention
NCT05104580
Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses
NCT02328820
Computed Tomography-derived Fractional Flow Reserve vs. Angiographic Quantitative Flow Ratio in Management of Patients With Coronary Artery Disease
NCT07308496
Comparison of Devices Evaluating Fractional Flow Reserve in Coronary Arteries
NCT03052803
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary analysis will be on the per-protocol principle (i.e. including all patients who are not protocol violators). A separate analysis will be performed on an intention-to-treat basis (i.e. all randomized patients randomized to a treatment arm).
Primary endpoint 1. Angina questionnaire
Secondary endpoints:
Number and % of patients undergoing PCI
Seattle Angina Questionnaire
* SAQ Physical limitation scale
* SAQ angina stability scale
* SAQ angina frequency scale
* SAQ quality of life
* SAQ Treatment Satisfaction Disease perception scale Follow-up (3 and 12 months) - Patient-oriented composite endpoint (death, myocardial infarction, unplanned revascularization) and its components.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Angiography
The indication to further coronary intervention will be based on angiographic diameter stenosis.
Assessment of angiographic severity of the stenosis
The indication to coronary stent intervention will be based on angiography
Quantitative flow ratio (QFR)
The indication to further coronary intervention will be based on QFR.
Quantitative flow ratio
Quantitative flow ratio (QFR) is a computer method that estimates the hemodynamic relevance of a coronary stenosis based on three-dimensional quantitative coronary angiography (3D QCA)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quantitative flow ratio
Quantitative flow ratio (QFR) is a computer method that estimates the hemodynamic relevance of a coronary stenosis based on three-dimensional quantitative coronary angiography (3D QCA)
Assessment of angiographic severity of the stenosis
The indication to coronary stent intervention will be based on angiography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least one additional intermediate stenosis (\>30% and \<90%).
* Patient ≥18 years old
Exclusion Criteria
* Persistent symptoms or evidence of ischemia requiring intervention of the non-culprit lesion.
* Any contraindication to PCI according to guidelines
* An ACS in the period following the index ACS and randomization
* TIMI (Thrombolysis in Myocardial Infarction) flow grade \< 3 in the culprit vessel
* Presence of thrombus in the non-culprit lesion
* Participation in another randomized interventional study interfering with the present protocol
* Patient unable to give informed consent
* Women of child-bearing potential or lactating
* Previous coronary artery bypass surgery CABG
* Recent (within 30 days) unsuccessful PCI
* Decompensated congestive heart failure (CHF) or hospitalization due to CHF during the last 3 months
* Left ventricular ejection fraction \<30%
* Severe chronic obstructive pulmonary disease (COPD)
* Severe valvular heart disease
* FFR (or RFR, iFR etc) assessment of non-culprit lesions at the time of the index procedure
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johannes Gutenberg University Mainz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tommaso Gori
Clinical Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center of Cardiology, Cardiology I, university hospital Mainz
Mainz, Rhineland-Palatinate, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ullrich-Daub H, Olschewski M, Schnorbus B, Belhadj KA, Kohler T, Vosseler M, Munzel T, Gori T. Quantitative flow ratio or angiography for the assessment of non-culprit lesions in acute coronary syndromes, a randomized trial. Clin Res Cardiol. 2025 Jun;114(6):729-737. doi: 10.1007/s00392-024-02484-5. Epub 2024 Jul 9.
Ullrich H, Olschewski M, Belhadj KA, Munzel T, Gori T. Quantitative Flow Ratio or Angiography for the Assessment of Non-culprit Lesions in Acute Coronary Syndromes: Protocol of the Randomized Trial QUOMODO. Front Cardiovasc Med. 2022 Apr 4;9:815434. doi: 10.3389/fcvm.2022.815434. eCollection 2022.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-15296
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.